Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ProVen VCT plc: Issue of Equity
-
-
EV Cargo Sharpens Strategic Focus on Global Forwarding
-
Bitfarms Schedules Fourth Quarter 2025 Conference Call on March 31, 2026
-
Clarios Connected Services introduces Battery Manager Pro at TMC 2026
-
Ms. Chafika Eddine joins Xali Gold Board of Directors
-
Vior Gold Corporation Intersects High-Grade Mineralization at Ligneris
-
Monte Rosa Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates
-
Verde Expands Minas Americas Magnet-Rich Ionic Clay Discovery Beyond 3.5 km²; MAV_AD_0028 Returns 10 m at 0.84% TREO
-
Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics
-
Two-Thirds of Canadians (67%) Say it’s Time to Abolish Tips, Reveals New H&R Block Canada Study
-
Goodfood Appoints Najib Maalouf as President and Chief Operating Officer
-
R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease
-
Guardian Capital Announces March 2026 Cash Distributions for Guardian Capital ETFs
-
Canfor Corporation completes acquisition of Canfor Pulp
-
Your360 AI Delivers What Surveys Can't: Team-Level Patterns From Confidential Voice Interviews
-
Troilus Signs Memorandum of Understanding With Boliden for Long‑Term Copper‑Gold Concentrate Offtake
-
Media Advisory: MADD Canada New Brunswick Police Awards to Launch in Fredericton
-
Yukon Metals Files Technical Report for the AZ Project, Yukon
-
Sono-Tek Announces Technical Collaboration with Diamond Quanta to Support Precision Coating Integration for Engineered Diamond Applications
-
Picard Medical / SynCardia Announce Successful Four-Year Bridge to Transplant with SynCardia Total Artificial Heart Support
-
Energys Group Announces Receipt of Determination Letter from Nasdaq Capital Market
-
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx’s Preservative-Free Ketamine Application
-
GDS Holdings Limited Reports Fourth Quarter and Full Year 2025 Results
-
Purple Biotech Regains Compliance with Nasdaq
-
Tower Semiconductor Extends its Leadership in BCD Performance with New Gen3 LDMOS Technology Addressing the ‘AI Power Wall’
-
Gyre Therapeutics Announces China’s NMPA Grants Priority Review to the NDA for Hydronidone (F351) for CHB-Induced Liver Fibrosis Treatment
-
Eupraxia Pharmaceuticals Reports Six-Month Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis
-
Troilus Signs Memorandum of Understanding With Boliden for Long‑Term Copper‑Gold Concentrate Offtake
-
Supply & Demand Chain Executive Honors GXO’s Sam Asher in the 2026 ‘Pros to Know’ Awards
-
Vireo Growth Inc. Announces Fourth Quarter 2025 Results
-
Telesat reports results for the quarter and twelve months ended December 31, 2025
-
Supply & Demand Chain Executive Honors GXO’s Sam Asher in the 2026 ‘Pros to Know’ Awards
-
EXL announces $125 million accelerated share repurchase program
-
Telesat adds military Ka-band to Telesat Lightspeed to meet strong global demand for defence and sovereignty requirements
-
Endogenex Announces Publication of REGENT-1 Clinical Study Results in Diabetes, Obesity and Metabolism
-
rPlus Energies Secures Financing Commitments for 400-Megawatt Blacks Creek Energy Center
-
Fractyl Health to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Updates on March 24, 2026
-
Coda Octopus Group Reports Fiscal First Quarter 2026 Financial Results
-
Transpire Bio Strengthens its Leadership Team with Appointment of Ewan Livesey as Head of Business Development
-
Your360 AI Delivers What Surveys Can't: Team-Level Patterns From Confidential Voice Interviews
-
IgNS and ACHC Launch New Distinction to Elevate Standards in Immunoglobulin Therapy
-
The five-step method that helps companies choose sustainable workwear
-
Aalberts reports the progress of its share buyback programme 09 – 13 March 2026
-
Surgence Labs Emerges as Preferred Crypto Marketing Agency for Top-Tier Venture-Backed Web3 Startups
-
YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
-
Change in the management board of group subsidiary
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRE HEALTHCARE GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PICTON PROPERTY INCOME LTD - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - LIFE SCIENCE REIT PLC - Ordinary Shares

